Article citationsMore>>

Bergman, L., Beelen, M.L., Gallee, M.P., Hollema, H., Benraadt, J. and van Leeuwen, F.E. (2000) Risk and Prognosis of Endometrial Cancer after Tamoxifen for Breast Cancer. Comprehensive Cancer Centres ALERT Group Assessment of Liver and Endometrial Cancer Risk Following Tamoxifen. Lancet, 356, 881-887.
http://dx.doi.org/10.1016/S0140-6736(00)02677-5

has been cited by the following article:

• TITLE: Uterine Inversion: An Uncommon Progressive Forme of Leiomyosarcoma Uterine: Case Report and Review of Literature

  AUTHORS: Apollinaire Gninlgninrin Horo, Kacou Edele Aka, Minata Fomba, Abdoul Koffi, N’guessan Alphonse Aman, Mohamed Kouyate, Konan Séni, Benjamin Effi, Koné Mamourou

  KEYWORDS: Leiomyosarcoma, Uterine Inversion, Externalized out of the Vulva

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.6 No.2, February 29, 2016

  ABSTRACT: Uterine leiomyosarcoma (LMS) is a rare uterine malignancy that represents approximately 1% of uterine cancers. The nonspecific symptoms cause difficulties in the diagnostic, prognostic and therapeutic. We report an unusual progressive form, with a uterine inversion of LMS fundal externalized out of the vulva in a patient of 48 years old premenopausal.